Floatz logo

Iron

Celiac Disease

Assistance Publique - Hôpitaux de ParisSmall moleculePhase 4 / ApprovedActive
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
89/ 100

Competitive context

15 Active assets in the Celiac Disease cohort.

Asset / SponsorPhaseRating
Necator Americanus
James Cook University, Queensland, Australia
Phase 2BB
MACROGOLS
Sheffield Teaching Hospitals NHS Foundation Trust
Phase 4BB
Larazotide
9 Meters Biopharma, Inc.
Phase 3BB
Latiglutenase
Entero Therapeutics
Phase 2BB
Prolyl Endopeptidase
Dr. C. Bonorino Udaondo Gastroenterology Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

Iron is also rated in:

iron deficiency anemiaActive
BB
Indicative · Phase 4
71 / 100
View asset →
colorectal neoplasmDormant
BB
Indicative · Phase 4
65 / 100
View asset →
pregnancy disorderDormant
D
Indicative · N/A
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →